Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey

被引:2
|
作者
Gebrehiwet, Paulos [1 ,5 ]
Brekke, Johan [2 ]
Rudnicki, Stacy A. [3 ]
Mellor, Jennifer [4 ]
Wright, Jack [4 ]
Earl, Lucy [4 ]
Ball, Nathan [4 ]
Iqbal, Halima [4 ]
Thomas, Owen [4 ]
Castellano, Giorgio [4 ]
机构
[1] Cytokinetics Inc, Hlth Econ & Outcomes Res, South San Francisco, CA USA
[2] Cytokinetics Inc, Med Affairs, South San Francisco, CA USA
[3] Cytokinetics Inc, Clin Res, South San Francisco, CA USA
[4] Adelphi Real World, Real World Evidence, Bollington, England
[5] Cytokinetics Inc, Hlth Econ & Outcomes Res, 350 Oyster Point Blvd, South San Francisco, CA 94080 USA
关键词
Amyotrophic lateral sclerosis; clinical milestones; progression; multinational; ALS; BODY-MASS INDEX; STAGING SYSTEM; ALSFRS-R; PROGRESSION; SURVIVAL; DIAGNOSIS; EPIDEMIOLOGY; PROGNOSIS; PATIENT; RISK;
D O I
10.1080/21678421.2023.2297795
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveTo determine the average time from Amyotrophic Lateral Sclerosis (ALS) symptom onset to 11 pre-defined milestones, overall and according to ALS progression rate and geographic location.MethodsData were drawn from the Adelphi Real World ALS Disease-Specific ProgrammeTM, a point-in-time survey of neurologists caring for people living with ALS (pALS) conducted in France, Germany, Italy, Spain, the United Kingdom and the United States from 2020-2021. ALS progression rate was calculated using time since symptom onset and ALS Functional Rating Scale Revised score.ResultsSurvey results were available for N = 1003 pALS (progression rate for N = 867). Mean time from symptom onset was 3.8 months to first consultation, 8.0 months to diagnosis, 16.2 months to employment change (part-time/sick leave/retirement/unemployment), 17.5 months to use of a walking aid, 18.5 months to first occurrence of caregiver support, 22.8 months to use of a wheelchair, 24.6 months to use of a communication aid, 27.3 months to use of a respiratory aid, 28.6 months to use of gastrostomy feeding, 29.7 months to use of eye gaze technology and 30.3 months to entering a care facility. Multivariate analysis indicated significant effects of fast (versus slow) progression rate on time to reach all 11 milestones, as well as US (versus European) location, age, body mass index and bulbar onset (versus other) on time to reach milestones.ConclusionspALS rapidly reached clinical and disease-related milestones within 30 months from symptom onset. Milestones were reached significantly faster by pALS with fast versus slow progression. Geographic differences were observed.
引用
收藏
页码:345 / 357
页数:13
相关论文
共 50 条
  • [31] The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey
    Wang, Zengwu
    Chen, Zuo
    Wang, Xin
    Zhang, Linfeng
    Li, Suning
    Tian, Ye
    Shao, Lan
    Hu, Hao
    Gao, Runlin
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (05): : 793 - 798
  • [32] Earlier Disease Onset in Non-Caucasian Amyotrophic Lateral Sclerosis (ALS) Patients: Retrospective Analysis from Two Tertiary Centers
    Ilieva, Hristelina
    Fernandez, Iago Pinal
    Natov, Peter
    Mosmiller, Elizabeth
    Clawson, Lora
    Simpson, Ericka
    Appel, Stanley
    Maragakis, Nicholas
    NEUROLOGY, 2016, 86
  • [33] Learning dynamic Bayesian networks from time-dependent and time-independent data: Unraveling disease progression in Amyotrophic Lateral Sclerosis
    Leao, Tiago
    Madeira, Sara C.
    Gromicho, Marta
    de Carvalho, Mamede
    Carvalho, Alexandra M.
    JOURNAL OF BIOMEDICAL INFORMATICS, 2021, 117
  • [34] Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and Germany
    Gorsh, B.
    Bracher, M.
    Symons, J. M.
    Nafees, B.
    Chauhan, D.
    Hoskin, B.
    Lucas, J.
    Kershaw, J.
    Middleton, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S515 - S516
  • [35] Tract-specific analysis improves sensitivity of spinal cord diffusion MRI to cross-sectional and longitudinal changes in amyotrophic lateral sclerosis
    Pramod Kumar Pisharady
    Lynn E. Eberly
    Ian Cheong
    Georgios Manousakis
    Gaurav Guliani
    H. Brent Clark
    Mark Bathe
    David Walk
    Christophe Lenglet
    Communications Biology, 3
  • [36] Tract-specific analysis improves sensitivity of spinal cord diffusion MRI to cross-sectional and longitudinal changes in amyotrophic lateral sclerosis
    Pisharady, Pramod Kumar
    Eberly, Lynn E.
    Cheong, Ian
    Manousakis, Georgios
    Guliani, Gaurav
    Clark, H. Brent
    Bathe, Mark
    Walk, David
    Lenglet, Christophe
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [37] Negative affect relates to cross-sectional but not longitudinal symptom reporting: Data from elderly adults
    Diefenbach, MA
    Leventhal, EA
    Leventhal, H
    PatrickMiller, L
    HEALTH PSYCHOLOGY, 1996, 15 (04) : 282 - 288
  • [38] Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study
    Ikeda, Ken
    Hirayama, Takehisa
    Takazawa, Takanori
    Kawabe, Kiyokazu
    Iwasaki, Yasuo
    INTERNAL MEDICINE, 2012, 51 (12) : 1501 - 1508
  • [39] Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis
    de Groot, Imelda J. M.
    Post, Marcel W. M.
    Van Heuveln, Tineke
    Van den Berg, Leonard H.
    Lindeman, Eline
    AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (06): : 356 - 361
  • [40] Dissociation of disease onset, progression and sex differences from androgen receptor levels in a mouse model of amyotrophic lateral sclerosis
    Tomas, Doris
    McLeod, Victoria M.
    Chiam, Mathew D. F.
    Wanniarachchillage, Nayomi
    Boon, Wah C.
    Turner, Bradley J.
    SCIENTIFIC REPORTS, 2021, 11 (01)